Research and Development

Showing 15 posts of 9603 posts found.

Merck image

Merck’s sleep aid drug meets goals

June 15, 2012 Research and Development, Sales and Marketing FDA, Merck, insomnia, sleep disorder, suvorexant

Merck’s novel insomnia drug suvorexant has improved patients’ ability to fall asleep, according to new data from two Phase III …
Deepak Khanna

UK drug pricing: ABPI wants evolution, not revolution

June 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, PPRS, VBP, pricing

 As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

New chair of Health Research Authority confirmed by DH

June 14, 2012 Medical Communications, Research and Development, Sales and Marketing

Professor Jonathan Montgomery will head up the Health Research Authority, the new organisation that will protect and promote the interests …
sanofi website

Positive data for Sanofi’s diabetes drug

June 13, 2012 Research and Development, Sales and Marketing Lyxumia, Novo Nordisk, Sanofi, Victoza, diabetes

Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …

New appointments at Events 4 Healthcare

June 13, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Events 4 Healthcare, NHS

Events 4 Healthcare has announced two new appointments to enhance the team on the back of a number of new …
screen_shot_2012-06-12_at_15

Ark Therapeutics appoints new head of business development

June 12, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ark Therapeutics, Bachem, Eden Biodesign, Watson

Ark Therapeutics has announced that Kassim Kolia has been appointed as head of business development.  In this role, Kolia will …

Sanofi submits key MS pill for approval

June 12, 2012 Research and Development, Sales and Marketing Bayer, EMA, FDA, Genzyme, Lemtrada, MS, Sanofi

Sanofi has submitted its multiple sclerosis pill Lemtrada for regulatory reviews in the US and Europe. Lemtrada (alemtuzumab), originally developed …
Jane Griffiths

Working Life: Jane Griffiths

June 11, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Working Life, brett wells, jane griffiths

After completing her PhD in Biochemistry at the University of Aberystwyth in 1982, Jane worked her way up the Johnson …

Contract research news in brief

June 11, 2012 Research and Development CRO, Complete Genomics, Foundation Medicine, Medtox Scientific and ERA Clinical, contract research, eResearch Technology

A round-up of news in the contract research services sector, including updates from Foundation Medicine, Complete Genomics, eResearch Technology, LabCorp …
screen_shot_2012-06-08_at_14

New COO for Lonza Life Science Ingredients

June 8, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Beat In-Albon, COO, Lonza

Lonza has appointed Beat In-Albon as chief operating officer of its Life Science Ingredients sector. In-Albon, 60, becomes a member …
John Lechleiter

Lechleiter wants policy that spurs innovation

June 8, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Lechleiter, Obama, PhRMA, US, heathcare, lilly

Lilly’s leader is calling on governments to take the long-term view when it comes to healthcare policy. John Lechleiter who …

Reducing Timelines Through Strategic Outsourcing

June 7, 2012 Research and Development

Frank Lis, Vice President & General Manager, Clinical Supply Services, explores the general effects brought on by the consolidation of …
RoActemra image

RoActemra superior to Humira as single-agent therapy

June 7, 2012 Research and Development, Sales and Marketing Humira, Orencia, RA, RoActemra, Roche. ADACTA

Roche’s RoActemra (tocilizumab) is more effective in treating rheumatoid arthritis as a single agent than market leader Humira, a new …

Former Teva president joins Sun Pharma

June 7, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Sun Pharma, Teva, generics, manufacturing

Sun Pharma has appointed Israel Makov as its new chairman of the board. Makov is the former president and chief …
ann_judge_2

Shire makes two senior appointments

June 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Colpman, Judge, Shire

Shire has announced the promotion of David Colpman and Ann Judge (pictured) as two senior leaders within the firm.  Colpman, …
The Gateway to Local Adoption Series

Latest content